Mad Hedge Technology Letter
June 21, 2018
Fiat Lux
Featured Trade:
(WHY NETFLIX IS UNSTOPPABLE),
(NFLX), (CAT), (AMZN), (CMCSA), (DIS), (FOX), (TWX), (GM), (WMT), (TGT)
Technology and biotechnology are the two seminal investment themes of this century.
And while many tech companies have seen share prices rise 100-fold or more since the millennium, biotech and its parent big pharma have barely moved the needle.
That is about to change.
You can thank the convergence of big data, supercomputing, and the sequencing of the human genome, which overnight, have revolutionized how new drugs are created and brought to market.
So far, only a handful of scientists and industry insiders are in on the new game. Now it's your turn to get in on the ground floor.
The first shot was fired in December 2017 when CVS (CVS) bought Aetna (AET) for an eye-popping $69 billion, puzzling analysts. A flurry of similar health care deals followed, with Berkshire Hathaway (BRK.A), Amazon (AMZN) with its Verily start-up, and J.P. Morgan (JPM) joining the fray.
March followed up with a Cigna (CI) bid for Express Scripts, a pharmacy benefits manager. Apple (AAPL) has suddenly launched a bunch of health care-based apps designed to accumulate its own health data pool.
What's it all about? Or better yet, is there a trade here?
No, it's not a naked bid for market share, or an attempt to front run the next change in health care legislation. It's much deeper than that.
In short, it's all about you, or your data to be more precise.
We have all seen those clever TV ads about IBM's (IBM) Watson mainframe computer knowing what you want before you do. In reality we are now on the third generation of Watson, known as Summit, now the world's fastest super computer.
Summit can process a mind-numbing 4 quadrillion calculations per second. This is computing muscle power that once was associated with a Star Trek episode.
Financed by the Department of Defense to test virtual nuclear explosions and predict the weather, Summit has a few other tricks up its sleeve. It can, for example, store every human genome and medical record of all 330 million people in the United States, process that data instantly, and spit out miracle drugs almost at whim.
You know all those lab tests, X-rays, MRI scans, and other tests you've been accumulating over the years? They add up to some 30% of the world daily data creation, or some 4 petabytes (or 4,000 gigabytes) a day. That's a lot of zeroes and ones.
Up until a couple of years ago, this data just sat there. It was like having a copy of the Manhattan telephone book (if it still exists) but not knowing anyone there. Thanks to Summit we now not only have a few friends in Manhattan, we know everyone's most intimate details.
I have been telling readers for years that if you can last only 10 more years you might be able to live forever, as all major human diseases will be cured during this time. Summit finally gives us the tools to achieve this.
Imagine the investment implications!
The U.S. currently spends more than $3 trillion on health care, or about 15% of GDP, and costs are expected to rise another 6% this year. To modernize this market, you will need to create from scratch four more Apples or six more Facebooks (FB) in terms of market capitalization. You can imagine what getting in early is potentially worth.
Crucial to all of this was Craig Venter's decoding of his own DNA in 2000 for the first time, which cost about $1 billion. Today, you and I can get 23andMe, Ancestry.com or Family Tree DNA to do it for $100, with most of the work done in China.
Of course, key to all of this is getting the medical data for every U.S. citizen on line as fast as possible. The Obama administration began this effort seven years ago. Remember those gigantic overstuffed records rooms at your doctor's office? You don't see them anymore.
But we have a long way to go, and 20% of the U.S. population who don't HAVE any medical records, including all of the uninsured, will be a challenge.
To give you some idea of the potential and convince that I have not gone totally MAD let me tell you about Amgen's (AMGN) sudden interest in Iceland. Yes, Iceland.
There, a struggling, young start-up named deCode sequenced the DNA of the entire population of the country, about 160,000 individuals. It tried to monetize its findings but it was early and lost money hand over fist. So, the company sold out to Amgen in 2012 for $415 million.
Until then targeting molecules for development was based on a hope and a prayer, and only a hugely uneconomic 5% of drugs made it to market. Using artificial intelligence (yes, those NVIDIA graphics processors again) to pretest against the deCode DNA data based it was able to increase that hit rate to 75%.
It's not a stretch to assume that a 15-fold increase in success rates leads to a 15-fold improvement in profitability, or thereabouts.
Word leaked out setting off a gold rush for equivalent data pools that led to the takeover boom described above. And what happens when the pool of data explodes from 160,000 individuals to 330 million? It boggles the mind.
As a result, the health care industry is now benefiting from a "golden age" of oncology. Average life expectancy for chemotherapies is increasing by months at a time for specific cancers.
All of this is happening at a particularly fortuitous time for drug, health care, and biotech companies, which are only just now coming out of a long funk.
Traders seemed to have picked up on this new trend in May, which is why I slapped on a long position in the iShares Nasdaq Biotechnology ETF (IBB) (click here for a full description).
Like many companies in the sector it is coming off of a very solid one-year double bottom and is going ballistic today.
The area is ripe for rotation. Other names you might look at include Biogen (BIIB), Celgene (CELG), and Regeneron (REGN).
If you have grown weary of buying big cap technology stocks at new all-time highs, try adding a few biotech and pharmaceutical stocks to spice this up. The results may surprise you.
As for living forever, that will be the subject of a future research piece. The far future.
Trade war? What trade war?
Apparently, nobody told Netflix (NFLX) that we are smack dab in a tit-for-tat trade war between two of the greatest economic powers to grace mankind.
No matter rain or shine, Netflix keeps powering on to new highs.
The Mad Hedge Technology Letter first recommended this stock on April 23, 2018, when I published the story "How Netflix Can Double Again," (click here for the link) and at that time, shares were hovering at $334.
Since, then it's off to the races, clocking in at more than $413 as of today, a sweet 19% uptick since my recommendation.
It seems the harder I try, the luckier I get.
What separates the fool's gold from the real yellow bullion are challenging market days like yesterday.
The administration announced a new set of tariffs on $200 billion worth of Chinese imports.
The day began early on the Shanghai exchange dropping a cringeworthy 3.8%.
The Hong Kong Hang Seng Market didn't fare much better cratering 2.78%.
Investors were waiting for the sky to drop when the minutes counted down to the open in New York and futures were down big premarket.
Just as expected, the Dow Jones Index plummeted on the open, and in a flash the Dow was down 410 points intraday.
The risk off appetite toyed with traders' nerves and American companies with substantial China exposure being rocked the hardest such as Caterpillar (CAT).
After the Dow hit an intraday low, a funny thing happened.
The truth revealed itself and U.S. equities reacted in a way that epitomizes the nine-year bull market.
Tar and feather a stock as much as you want and if the stock keeps going up, it's a keeper.
Not only a keeper, but an undisputable bullish signal to keep you from developing sleep apnea.
In the eye of the storm, Netflix closed the day up a breathtaking 3.73%. The overspill of momentum continued with Netflix up another 2% and change today.
This company is the stuff of legends and reasons to buy them are legion.
As subscriber surveys flow onto analysts' desks, Netflix is the recipient of a cascade of upgrades from sell side analysts scurrying to raise targets.
Analysts cannot raise their targets fast enough as Netflix's price action goes from strength to hyper-strength.
Chip stocks have the opposite problem when surveys, portraying an inaccurate picture of the 30,000-foot view, prod analysts to downgrade the whole sector.
That is why they are analysts, and most financial analysts these days are sacked in the morning because they don't understand the big picture.
Quality always trumps quantity. Period.
Netflix has stockpiled consecutive premium shows from titles such as Stranger Things, The Crown, Unbreakable Kimmy Schmidt, and Orange is the New Black.
This is in line with Netflix's policy to spend more on non-sports content than any other competitors in the online streaming space.
In 2017, Netflix ponied up $6.3 billion for content and followed that up in 2018, with a budget of $8 billion to produce original in-house shows.
Netflix hopes to increase the share of original content to 50%, decoupling its reliance on traditional media stalwarts who hate Netflix's guts with a passion.
A good portion of this generous budget will be deployed to make 30 new anime shows and 80 new original films all debuting by the end of 2018.
Amazon's (AMZN) Manchester by the Sea harvested two Oscars for its screenplay and Casey Affleck's performance, foreshadowing the opportunity for Netflix to win awards next time around, potentially boosting its industry profile.
It will only be a matter of time because of the high quality of production.
Netflix's content budget will dwarf traditional media companies by 2019, creating more breathing room against the competitors who have been late to the party and scrambling for scraps.
This is what Disney's futile attempts to take on Netflix, which raised its offer for Fox to $71.3 billion to galvanize its content business.
Disney's (DIS) bid came on the heels of Comcast Corp. (CMCSA) bid for Disney at $65 billion.
The sellers' market has boosted all content assets across the board.
Remember, content is king in this day and age.
In 2017, Time Warner (TWX) and Fox (FOX) spent $8 billion each and Disney slightly lagged with a $7.8 billion spend on non-sports programming.
Netflix will certainly announce a sweetened content outlay of somewhere close to $9.5 billion next year attracting the best and brightest to don the studios of Netflix.
What's the whole point of creating the best content?
It lures in the most eyeballs.
Subscriber growth has been nothing short of spectacular.
Expectations were elevated, and Netflix delivered in spades last quarter adding quarterly total subscribers to the tune of 7.41 million versus the 6.5 million expected by analysts.
Not only a beat, but a blowout of epic proportions.
Inside the numbers, rumors were adrift of Netflix's domestic numbers stagnating.
Consensus was proved wrong again, with domestic subscribers surging to 1.96 million versus the 1.48 million expected.
The cycle replays itself over. Lather, rinse, repeat.
Quality content attracts a wave of new subscribers. Robust subscriber growth fuels more spending, which paves the way for more quality content.
This is Netflix's secret formula to success.
Netflix has executed this strategy systemically to the aghast of traditional media companies that are stuck with legacy businesses dragging them down and making it decisively difficult to compete with the nimble online streaming players.
Turning around a legacy business is tough work because investors expect profits and curse the ends of the earth if companies spend big on new projects removing the prospects of dividend hikes.
Netflix and the tech darlings usually don't make a profit but have a license to spend, spend, and spend some more because investors are on board with a specific narrative prioritizing market share and posting rapid growth.
The cherry on top is the booming secular story happening as we speak in Silicon Valley.
Effectively, all other sectors that are not tech have become legacy sectors thanks in large part to the high degree of innovation and cross-functionality of big cap tech companies.
The future legacy winners are the legacy stocks and sectors reinventing themselves as new tech players such as General Motors (GM), Walmart (WMT), and Target (TGT).
The rest will die a miserably and excruciatingly slow death.
The Game of Thrones M&A battle with the traditional media companies is a cry of desperate search for these dinosaurs.
They were too late to react to the Netflix threat and were punished to full effect.
Halcyon days are upon Netflix, and this company controls its own destiny in the streaming wars and online streaming content industry.
As history shows, nobody executes better than CEO Reed Hastings at Netflix, which is why Netflix maintains its grade as a top 3 stock in the eyes of the Mad Hedge Technology Letter.
_________________________________________________________________________________________________
Quote of the Day
"I got the idea for Netflix after my company was acquired. I had a big late fee for Apollo 13. It was six weeks late and I owed the video store $40. I had misplaced the cassette. It was all my fault," - said cofounder and CEO of Netflix Reed Hastings.
Global Market Comments
June 20, 2018
Fiat Lux
Featured Trade:
(ANNOUNCING THE MAD HEDGE LAKE TAHOE, NEVADA, CONFERENCE, OCTOBER 26-27, 2018),
(THE CHINA TRADE WAR TURNS HOT),
(GM), (AAPL), (SOYB), (WEAT), (CORN)
The trade war with China has suddenly gone from small beer to a big deal. In just two months, we have gone from campaign promises to threats, to an increase in duties from $50 billion to $250 billion worth of Chinese imports.
The risk of destroying the current strength of the economy and the stock market is now on the table. Already, the Dow Average has given up all its 2018 gains and is now down 1.1% on the year.
All we will be left with is a big tax cut for corporations, $3 trillion in new government debt, and a recession.
As a result, the current rally in the stock market will fail, and a test of the 2018 lows is on the menu. My 2018 range for stocks until the midterm election lives!
Of the past 10 years, China has generated 50% of global economic growth, the U.S. 35%, and the rest of the world the balance. Imports from the U.S. to China were already on a sharp upswing, and it is now our third largest trading partner.
Imports of U.S. autos has soared from 125,356 units in 2011 to 267,473 in 2017, and that doesn't count American cars, such as the GM Buick, built in China. It now looks like all of this will suddenly grind to a halt.
Not only will Chinese middle-class consumers buy European and Japanese going forward, the American brand has been destroyed by our open hostility and insults. Apple (AAPL) sells more iPhones in China than the U.S., but I'm not sure that will last either.
China only imported $150 billion worth of goods from the U.S. last year. That means to implement a tit-for-tat, dollar-for-dollar retaliation China will have to hit the U.S. services sector hard. Similarly, you can bet that Chinese investment in the U.S. will be sharply curtailed.
The true cost of the trade war isn't in the dollar amounts involved ... yet. But the impact on business confidence has been catastrophic.
Investment globally is slowing because nobody knows if their industry, or their company will get hit next by American off-the-cuff policies. Just ask any soybean (SOYB) farmer who is looking at a de facto ban on Chinese purchases of their products. The price of their commodity has collapsed by 16% in a week.
In the end, Trump will get what he wants, a lower U.S. trade deficit. But it will come in the form of collapsing demand from U.S. consumers generated by the next recession. That is the only way the American trade deficit has fallen for the past century.
Be careful what you wish for.
Mad Hedge Technology Letter
June 20, 2018
Fiat Lux
Featured Trade:
(GOOGLE'S GRAND CHINA PLAY),
(BABA), (JD), (GOOGL), (AAPL), (BIDU), (AMZN), (NFLX)
There is light at the end of the tunnel.
A glimmer of hope is better than nothing.
Stolen IP was yesterday's story.
The administration's attempts to stick China with the bill is a waste of time.
The stock market is forward-looking and that is what I focus on when writing the Mad Hedge Technology Letter.
American tech companies want to turn over this bitter page of history and construct a fruitful future.
Ironically, it could be no other than American large tech companies that solves this trade misunderstanding by embracing Chinese tech instead of dragging them through the embers of political chaos.
That is what this groundbreaking partnership between Alphabet (GOOGL) and China's second largest e-commerce company JD.com (JD) is telling us.
If American and Chinese tech agree to fuse together through different M&A activity, strategic partnerships, and engineering projects, slapping penalties on your own interests would be without basis.
Albeit gone are the yesteryears of complete ownership on the other's turf, a medium ground could be found to satisfy both parties.
Alphabet's $550 million investment will give it 27 million shares of JD.com Class A shares equating to a 1% stake in JD.com.
JD.com products will now be hawked on Google Shopping, a platform giving users a chance to compare different price points from various sellers.
JD.com's fresh links with Silicon Valley's original powerhouse is timely because its business-to-consumer retail sales have slightly dipped in form from 27% last year to an underwhelming 25% in the first quarter of 2018.
Alibaba (BABA), the Amazon of China, is the 800-pound gorilla in the room and has a stranglehold on this market, carving out a robust 60% of sales from business to consumer retail.
Chinese companies have never worried about foreign companies seizing market share in China because they know the rigid operating environment mixed with "cultural" barriers will lead to a rapid demise.
Chinese firms are channeling their distress toward local competitors that understand the market as well as they do and number in the 100s in any one industry.
This is also a huge bet on the Chinese consumer who has put the world economy on its back creating the lions' share of global growth for the past 10 years.
Do not bet against China and the Chinese consumer.
Alphabet is taking this sentiment to the bank by integrating part of a premium Chinese tech firm into its own top line performance.
This investment would not happen if Alphabet believed the trade war could turn draconian cannibalizing each other's profit engines.
Alphabet has obviously been reading the tea leaves from the Mad Hedge Technology Letter as I identified China's huge competitive advantage in Southeast Asia and the huge potential for Chinese companies that migrate there.
The pivot toward Southeast Asia was the deal clincher for Alphabet and rightly so.
Alphabet has also invested in opening an A.I. (artificial intelligence) lab in Beijing showing its determination to extract a piece of the pie from China and ensuring their brand power is maintained in the Middle Kingdom.
Google search has been shut down on mainland China since 2010. Therefore, Alphabet needs to find alternative ways to benefit from the Chinese consumer and increase its presence.
The writing on the wall was when Baidu (BIDU) came to the fore with its own Chinese version of Google search.
Opportunities on the mainland have been scarce ever since the appearance of Baidu.
Apple (AAPL) has been the premier role model in China successfully juggling the complexities of the Chinese market. A big part of its staying power is offering local Chinese jobs.
Not just a few jobs, but millions.
As of April 2017, an Apple press release stated, "Apple has created and supported 4.8 million jobs in China" which is almost three times more than in America.
Apple deploys much of its supply chain around the mainland and taking down Apple in a trade war would strip millions of Chinese jobs in one fell swoop.
Not only that, Apple has deeply invested in data centers located in China and opened research centers in Shanghai and Suzhou.
Foxconn, a company responsible for assembling iPhones in mainland China, employs 1.2 million alone.
Alphabet would be smart to follow in the same footsteps, effectively, morphing into a hybrid Chinese company employing locals in droves and allowing millions of Chinese to earn their crust of bread through local factories.
Let me be clear: This would not hurt its business back at home.
It is also wrong to say that China is saturating because the 6.8% annual growth rate in China is a firm vote of confidence for Chinese discretionary spenders.
However, instead of competing head to head under the scrutiny of Chinese regulators, it is much more sensical to copy SoftBank's Masayoshi Son's lead when he invested $25 million in Jack Ma's Alibaba in 1999.
SoftBank's 1999 investment is now valued at more than $30 billion as of the current share price today.
Yahoo later joined the party in 2005, investing $1 billion into Alibaba and that stake is worth many times over.
Instead of fighting through cultural norms and fighting against the throes of an exotic business environment, paying for a stake and leaving its nose out of it has shown to be demonstrably effective.
Partnerships complicate the relationship, but if management can lock down each side's commitment to the very T, collaboration could spur even more innovation benefiting both countries and bottom lines.
China has draconian Internet controls put in place. American tech companies aren't up to snuff with cultural maneuverability to navigate through these shark-infested waters.
Better to pay for a stake and pick up the check after the market close.
Another winner in this deal is tech valuations, which has been the Cinderella story of 2018.
Although American tech companies will probably never be able to own 100% of a Chinese BAT. However, allowing these types of investments to go ahead is certainly bullish for equities.
Tech is still the sector lifting the heavy weight stateside and promoting innovation through collaboration will do a great deal to win the hearts and minds of Chinese people, companies and government.
As much as China hates the stain to its image of this nebulous trade war, it still deeply respects and admires large-cap American tech companies.
Chinese Millennials particularly have a deep love affair with Tesla's Elon Musk. They are captivated by his braggadocio, which they find appealingly exotic and captivatingly un-Chinese.
Through this partnership, JD.com will learn heaps about cutting-edge ad-tech and is guaranteed to apply the know-how to its home user base. In return, Alphabet will get deep insights of how JD.com controls the entire logistical experience and how a Chinese tech behemoth operates its supply chain.
The nuggets of information pocketed will help Alphabet compete more with Amazon back at home.
This is a win-win proposition.
Adding even more cream on top, enhanced brand awareness by joining together with Google could catapult JD.com into the shop window of America's consciousness.
Up until today, JD.com is hardly known about in the West except for specialists that avidly follow technology like the Mad Hedge Technology Letter.
I reiterate my stance of not buying into Chinese tech companies, and readers would be better served buying Microsoft (MSFT), Amazon (AMZN), and Netflix. (NFLX)
It makes no sense to trade stocks mired in the heart of a trade war.
As much as I love Alibaba as a company, it has been trading in a range because of the whipsawing headlines released in the press.
However, I can stand from afar and admire how the Chinese BATs have advanced in such a short amount of time.
If American tech and Chinese tech merge to the point of unrecognizability, consolidation could create a super tech power comprising of mixed Chinese and American interests.
Instead of bickering at each other, other solutions look to be more compelling.
The world's economy needs a healthy Chinese economy and vibrant Chinese consumer.
If the Chinese economy ever fell off a cliff, you can kiss this nine-year equity bull market goodbye, and the Mad Hedge Technology Letter would turn extremely bearish in a blink of an eye.
Therefore, America has a large stake in not alienating the Mandarins to the point of disgust.
I am still bullish on equities, but vigilance is the name of the game for short-term traders.
Package Delivery!
_________________________________________________________________________________________________
Quote of the Day
"My belief is that one plus one equals three. The pie gets larger, working together," Apple CEO Tim Cook said about its operations in mainland China and working with the Chinese Communist government.
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more